| abstract |
Compositions, kits and methods comprising an interleukin (IL) conjugate (eg, an IL-2 conjugate) in combination with other agents or methods useful for the treatment of one or more indications, such as treatment of a proliferative disease, include disclosed herein. Also described herein are pharmaceutical compositions and kits comprising one or more interleukin conjugates (eg, IL-2 conjugates). |